ID2 and hepatocellular carcinoma: Further investigation revealed that the β-catenin downstream gene ID2 is responsible for the oncogenic activity of PRDX4 in hepatocellular carcinoma (HCC) cells, promoting anchorage-independent growth and anoikis resistance (40).